Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban

Stroke patients can recover upon intravenous thrombolysis but remain impaired in lacking recanalization. We sought to investigate the clinical effect of systemic thrombolysis with an intravenous bolus of 20 mg recombinant tissue plasminogen activator (rtPA) and an infusion of body-weight adjusted ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Seitz, Rüdiger J., Sukiennik, Judith, Siebler, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490474/
https://www.ncbi.nlm.nih.gov/pubmed/23139853
http://dx.doi.org/10.4081/ni.2012.e9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490474/
https://www.ncbi.nlm.nih.gov/pubmed/23139853
http://dx.doi.org/10.4081/ni.2012.e9

Ejemplares similares